v3.23.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Research and development (“R&D”) expenses, net $ 16,244 $ 22,676
Amortization of intangible assets 1,519 1,519
General and administrative expenses 9,456 11,267
Operating loss 27,219 35,462
Other income (134)
Interest expenses 2,069 699
Financial income, net (902) (2)
Loss before tax 28,252 36,159
Tax expenses 65 67
Net Loss $ 28,317 $ 36,226
Basic and diluted loss per share of Common Stock (in Dollars per share) $ 0.95 $ 1.39
Weighted average number of shares of Common Stock outstanding, basic and diluted (in Shares) 29,854,003 26,007,947

Source